NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-68

  1. 132 Posts.
    lightbulb Created with Sketch. 35
    Congrats to all longs- alot more to come!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.